Morbilliform Eruptions in the Hospitalized Child

Haber, Jessica S.; Cipriano, Sarah D.; Oza, Vikash S.

doi:10.1016/j.det.2021.12.006

Cited by 2 publications

(1 citation statement)

References 68 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Morbilliform eruptions have a wide variety of possible causes. These eruptions may present due to some infectious causes, such as measles, drug eruptions, and inflammatory conditions, such as Kawasaki disease 22 . Morbilliform eruptions are frequently observed in pediatric inpatients and have been identified as a common dermatological manifestation of SARS‐CoV‐2 infection in children 23 …”

Section: Discussionmentioning

confidence: 99%

Skin manifestations in children with MIS‐C and COVID‐19: a narrative review

Sati,

Alzraikat,

Milan

et al. 2023

Int J Dermatology

View full text Add to dashboard Cite

This review aims to highlight the diverse skin manifestations in children and adolescents with COVID induced multisystem inflammatory syndrome in children (MIS‐C). The symptoms of COVID‐19 can vary greatly in severity between different age groups. Although most children infected with SARS‐CoV‐2 experience either no symptoms or only mild symptoms, some reported cases of severely affected children with a clinical presentation similar to incomplete Kawasaki disease have led to the definition of a new condition called MIS‐C. MIS‐C can involve multiple organs, including the skin, and may pose a life‐threatening risk to affected children. Such cases highlight the need for continuous research into the possible skin manifestations associated with COVID‐19 in pediatric populations to aid in early diagnosis and prompt treatment. We conducted a search of PubMed, Scopus, and ScienceDirect databases for studies published up until October 1, 2022. Three reviewers independently examined each study, and a fourth reviewer resolved any disagreements. A narrative review of all relevant papers was conducted. We present an overview of the clinical presentation, pathophysiology, diagnosis, and treatment of the various skin manifestations in children and adolescents with COVID‐19 or MIS‐C. The skin manifestations of COVID‐19 and MIS‐C can be diverse and are frequently overlooked. It is important to conduct further research to better understand the impact of this disease on children to provide appropriate care for these at‐risk populations.

show abstract

Section: Discussionmentioning

confidence: 99%

Skin manifestations in children with MIS‐C and COVID‐19: a narrative review

Sati,

Alzraikat,

Milan

et al. 2023

Int J Dermatology

View full text Add to dashboard Cite

show abstract

Infecciones exantemáticas de la infancia

Sarmiento Rivera

2024

View full text Add to dashboard Cite

Debido a las aparentes similitudes entre las presentaciones de los exantemas en la infancia, es apenas comprensible que enfrentarse a este tipo de pacientes genere temor; sin embargo, plantearse un panorama de las posibles causas (infecciones, alergias a medicamentos o enfermedades sistémicas…) y realizar un abordaje integral que incluya una historia clínica completa y un examen físico detallado, nos permitirá reducir considerablemente el espectro.

show abstract

Morbilliform Eruptions in the Hospitalized Child

Cited by 2 publications

References 68 publications

Skin manifestations in children with MIS‐C and COVID‐19: a narrative review

Skin manifestations in children with MIS‐C and COVID‐19: a narrative review

Infecciones exantemáticas de la infancia

Contact Info

Product

Resources

About